Submitted by: Submitted by muskanpatil
Views: 10
Words: 427
Pages: 2
Category: Science and Technology
Date Submitted: 02/23/2016 03:08 AM
Glaucoma market, Key Trends, Application Analysis, Regional Outlook & Forecasts to 2016
Global Markets Direct's, 'Glaucoma - Pipeline Review, H2 2015', provides an overview of the Glaucoma's therapeutic pipeline.
This report provides comprehensive information on the therapeutic development for Glaucoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Glaucoma and special features on late-stage and discontinued projects.
Browse Detail Report With TOC @ http://www.radiantinsights.com/research/glaucoma-pipeline-review-h2-2015
Reasons to Buy
Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Develop strategic initiatives by understanding the focus areas of leading companies
Identify and understand important and diverse types of therapeutics under development for Glaucoma
Table Of Content
Table Of Contents 2
List of Tables 6
Buy a Sample copy of This Report @ http://www.radiantinsights.com/checkout/145804
List of Figures 9
Introduction 10
Global Markets Direct Report Coverage 10
Glaucoma Overview 11
Therapeutics Development 12
Pipeline Products for Glaucoma - Overview 12
Pipeline Products for Glaucoma - Comparative Analysis 13
Glaucoma - Therapeutics under Development by Companies 14
Glaucoma - Therapeutics under Investigation by Universities/Institutes 20
Glaucoma - Pipeline Products Glance 21
Late Stage Products 21
Clinical Stage Products 22
Early Stage Products 23
Unknown Stage Products 24
Glaucoma - Products under Development by Companies 25
Glaucoma -...